LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

ABBV

225.16

+3.14%↑

UNH

327.41

+1.82%↑

AZN

89.05

+1.79%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

ABBV

225.16

+3.14%↑

UNH

327.41

+1.82%↑

AZN

89.05

+1.79%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

ABBV

225.16

+3.14%↑

UNH

327.41

+1.82%↑

AZN

89.05

+1.79%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

ABBV

225.16

+3.14%↑

UNH

327.41

+1.82%↑

AZN

89.05

+1.79%↑

LLY

988.07

+2.29%↑

JNJ

193.84

+3.17%↑

ABBV

225.16

+3.14%↑

UNH

327.41

+1.82%↑

AZN

89.05

+1.79%↑

Начало・Списък с акции・McKesson Corp

McKesson Corp

Затворен

СекторЗдравеопазване

855.37 -0.34

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

851.18

Максимум

860.61

Ключови измерители
By Trading Economics
Приходи	426M 1.2B
Продажби	5.3B 103B
P/E Средно за сектора	26.881 105.69
EPS	9.86
Дивидентна доходност	0.35
Марж на печалбата	1.173
Служители	43,000
EBITDA	212M 1.5B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+6.58% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	0.35% 2.37%
Следваща дата на дивидент	2.01.2026 г.
Следваща дата на екс-дивидент	1.12.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	4B 106B
Предишно отваряне	855.71
Предишно затваряне	855.37

Настроения в новините

By Acuity

36%

64%

130 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

681.92 / 707.28 Подкрепа & съпротива

McKesson Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.11.2025 г., 23:59 ч. UTC

Печалби

Singtel's 1st Half Net Profit Surges

11.11.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Mineral Resources Sells Stake in Lithium Mines to Posco For $765 Million

11.11.2025 г., 22:21 ч. UTC

Печалби

Aristocrat Boosts Dividend as Annual Profit Rises 12%

11.11.2025 г., 23:52 ч. UTC

Пазарно говорене

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

11.11.2025 г., 23:44 ч. UTC

Печалби

Singtel's 1H Net Profit Surges

11.11.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Trade Rangebound Amid Caution over U.S. Econ Strength -- Market Talk

11.11.2025 г., 23:18 ч. UTC

Печалби

Singtel: Expects FY Operating Company EBIT to Grow Between High Single Digits and Low Double Digits Vs. Earlier Guidance of High Single-Digit Growth >Z74.SG

11.11.2025 г., 23:15 ч. UTC

Печалби

Singtel: Interim Dividend of 8.2 Singapore Cents per Share, up 17% >Z74.SG

11.11.2025 г., 23:14 ч. UTC

Печалби

Singtel 1H Underlying Net Profit S$1.35B, Up 14% >Z74.SG

11.11.2025 г., 23:12 ч. UTC

Печалби

Singtel 1H Net Exceptional Gain of S$2.05B >Z74.SG

11.11.2025 г., 23:11 ч. UTC

Печалби

Singtel 1H Net S$3.40B Vs. Net S$1.23B >Z74.SG

11.11.2025 г., 23:10 ч. UTC

Печалби

Singtel 1H Rev S$6.91B Vs. S$6.99B >Z74.SG

11.11.2025 г., 23:04 ч. UTC

Пазарно говорене

RBA Will Sharply Focus On Australian Jobs Report -- Market Talk

11.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

11.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Health Care Roundup: Market Talk

11.11.2025 г., 21:46 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Private Equity Can Benefit From 'Deal-Friendly' Antitrust Policies -- Market Talk

11.11.2025 г., 21:41 ч. UTC

Печалби

Aristocrat: Continues to Actively Pursue Strategic M&A Opportunities

11.11.2025 г., 21:40 ч. UTC

Печалби

Aristocrat: Expects to Deliver Npata Growth Over FY 2026 on a Constant Currency Basis

11.11.2025 г., 21:39 ч. UTC

Печалби

Aristocrat: Interactive Delivered Revenue Growth Mainly Due to Inclusion of NeoGames

11.11.2025 г., 21:39 ч. UTC

Печалби

Aristocrat: Key Social Casino Franchises Continued to Outperform Market

11.11.2025 г., 21:39 ч. UTC

Печалби

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

11.11.2025 г., 21:38 ч. UTC

Печалби

Aristocrat: FY Normalized Npata Up 9% in Constant Currency

11.11.2025 г., 21:38 ч. UTC

Печалби

Aristocrat: Final Dividend 49 Australian Cents/Share

11.11.2025 г., 21:37 ч. UTC

Печалби

Aristocrat: FY Statutory Net Profit from Continuing Ops A$1.18 Bln, Up 2.9%

11.11.2025 г., 21:36 ч. UTC

Печалби

Aristocrat: FY Normalized Operating Revenue A$6.3 Bln, Up 11%

11.11.2025 г., 21:35 ч. UTC

Печалби

Aristocrat: FY Normalized Npata A$1.55 Bln, Up 12.2%

11.11.2025 г., 21:35 ч. UTC

Печалби

Alcon 3Q Adj EPS 79c >ALC

11.11.2025 г., 21:35 ч. UTC

Печалби

Alcon 3Q Rev $2.61B >ALC.EB

11.11.2025 г., 21:35 ч. UTC

Печалби

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11.11.2025 г., 21:35 ч. UTC

Печалби

Alcon 3Q EPS 48c >ALC.EB

Сравнение с други в отрасъла

Ценова промяна

McKesson Corp Прогноза

Ценова цел

By TipRanks

6.58% нагоре

12-месечна прогноза

Среден 915.92 USD 6.58%

Висок 1,000 USD

Нисък 775 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за McKesson Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на McKesson Corp през последните 3 месеца.

Техническа оценка

By Trading Central

681.92 / 707.28Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There are no events.

Настроение

By Acuity

130 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.